Shares of FibroGen (FGEN) rose 6.09% to $14.56 at 14:17 EST on Tuesday, after three successive sessions in a row of losses. NASDAQ Composite (FGEN) is rising 1.43% to $14,479.63, after five successive sessions in a row of losses. This seems, at the moment, an all-around bullish trend trading session today.

FibroGen’s last close was $13.72, 76.02% below its 52-week high of $57.21.


Today’s last reported volume for FibroGen is 1310859 which is 6.4% above its average volume of 1232063.

The company’s growth estimates for the ongoing quarter is 52.6% and a drop 60% for the next.

FibroGen’s Revenue

Year-on-year quarterly revenue growth grew by 57.5%, now sitting on 190.35M for the twelve trailing months.


FibroGen’s last week, last month’s, and last quarter’s current volatility was a positive 0.47%, a negative 0.09%, and a positive 2.47%, respectively.

FibroGen’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.30% (last week), 2.27% (last month), and 2.47% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

FibroGen’s stock is considered to be overbought (>=80).

FibroGen’s Stock Yearly Top and Bottom Value

FibroGen’s stock is valued at $14.56 at 14:17 EST, way below its 52-week high of $57.21 and above its 52-week low of $13.25.

FibroGen’s Moving Average

FibroGen’s worth is way under its 50-day moving average of $25.19 and way below its 200-day moving average of $32.00.

More news about FibroGen (FGEN).


Please enter your comment!
Please enter your name here